Track the 3D Medicines Inc. stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €638.2m. The latest transaction was filed on 18 August 2026 (Other). Among the most active insiders: Zhu Jinqiao. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
3D Medicines Inc. is a company focused on developing innovative therapies for cancer treatment. It specializes in the research and commercialization of drugs based on advanced technologies.